Active

Uncovering how the tumour microenvironment can make cancer cells more aggressive

Cancer types:

Head & neck cancer

Project period:

Research institute:

Consejo Superior Investigaciones Cientificas and Universidad Autonoma de Madrid (CSIC-UAM)

Award amount:

£166,604

Location:

Spain

Leandro Sastre Garzon Headshot
Researcher Professor Leandro Sastre Garzón

Professor Sastre Garzón and his team are studying how oral cancer cells gain the ability to spread into other tissues. They hope to find ways to prevent metastasis or treat cancer that has already spread.

Hope for the future

Most cancer deaths are ultimately caused my metastasis, where cells spread from the original tumour to other places around the body. Cancer cells often change and gain the ability to spread, and they can be influenced to do so by the environment around them in the tumour. 

Professor Sastre Garzón and his team are studying how the tumour microenvironment influences oral cancer cells to change, giving them the ability to spread to other places in the body. They hope that uncovering this process will reveal new ways to treat cells that have already spread, or even prevent it happening. 

Leandro Sastre Garzon and Team
Meet the scientist

Professor Sastre Garzón started working in cancer hoping to apply his experience in other areas of biology to a big problem for society – he is supported by his wife and daughter, both of whom are also cancer researchers! Outside of the lab, he enjoys reading and learning about history, and has one dog, two cats, and a variety of plants at home.

The science

Tumours are not just a bundle of identical cancer cells; in fact, they are complex ecosystems made up of cancer cells and many other types of cell. Together they form something called a tumour microenvironment. In a similar way to how soil nurtures plants to grow, the tumour microenvironment helps the tumour to grow and spread. 

In oral cancer, a type of head and neck cancer, the main cells in the tumour microenvironment that influence this change are cancer-associated fibroblasts (CAFs). They disrupt the cellular machinery that reads instructions off DNA. This causes the cancer cells to change and gives them the ability to spread into surrounding tissue through the ‘soil’ and colonise other areas. 

Professor Sastre Garzón and his team want to understand how the CAFs communicate with the cancer cells to cause that change. They hope that unpicking this process will reveal new ways to prevent this spread happening or destroy the cells that have already spread. 

I believe that science is a major driver of the advance of our society. I think this is the case in many fields and also in biomedical sciences. Discovery research is basic in this advance as shown in many social and medical improvements that followed discovery research findings.

Leandro Sastre Garzon Headshot
Professor Leandro Sastre Garzón

Related projects

Alfonso Calvo and Team

Active Spain

Lung cancer

Can we stop cancers hiding from immunotherapy?

This project hopes to find a way for immunotherapies to work better, for more cancer patients. Using cutting-edge technologies they will test out a potential new way to treat cancer and explore how to advance it towards the clinic. 

Researcher: Dr Alfonso Calvo

Can we stop cancers hiding from immunotherapy?
Tanya Stoyanova Group Shot

Active USA

Breast cancer

Can we use ‘minibodies’ to detect and treat cancer?

This project hopes to develop a new way to identify and target prostate and breast cancer cells in the body using tiny molecular ‘flags’, called minibodies. 

Researcher: Dr Tanya Stoyanova

Mini but mighty: Using ‘minibodies’ to detect and treat breast and prostate cancer
Headshot of Worldwide Cancer Research scientist Dr Claire Fletcher

Active United Kingdom

Prostate cancer

Can we damage prostate cancer cells with a tiny DNA-like material?

This project aims to find vital new treatments for advanced prostate cancer that stops responding to other treatments or comes back after treatment.

Researcher: Dr Claire Fletcher

Developing a brand-new treatment for advanced prostate cancer
Share this page